Barclays
ZURA icon

Barclays’s Zura Bio ZURA Stock Holding History

Barclays’s Portfolio ZURA Stock Details ZURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.08M Buy
258,666
+152,920
+145% +$817K ﹤0.01% 3000
2026
Q2 		$624K Sell
105,746
-64,087
-38% -$305K ﹤0.01% 3094
2026
Q1 		$1.01M Buy
169,833
+121,172
+249% +$732K ﹤0.01% 2758
2025
Q4 		$255K Buy
48,661
+48,659
+2,432,950% +$192K ﹤0.01% 4198
2025
Q3 		$9 Hold
2
– – ﹤0.01% 5402
2025
Q2 		$2 Sell
2
-55,757
-100% -$66.7K ﹤0.01% 5191
2025
Q1 		$71.9K Sell
55,759
-22,764
-29% -$35.9K ﹤0.01% 4507
2024
Q4 		$196K Buy
78,523
+14,462
+23% +$51.5K ﹤0.01% 4323
2024
Q3 		$260K Buy
64,061
+56,757
+777% +$212K ﹤0.01% 4158
2024
Q2 		$25.6K Sell
7,304
-5,032
-41% -$20.5K ﹤0.01% 4396
2024
Q1 		$31.7K Sell
12,336
-11,275
-48% -$40K ﹤0.01% 4695
2023
Q4 		$110K Buy
23,611
+21,406
+971% +$107K ﹤0.01% 4618
2023
Q3 		$14.6K Buy
2,205
+696
+46% +$4.65K ﹤0.01% 4238
2023
Q2 		$12.4K Buy
+1,509
New +$12.1K ﹤0.01% 4205

Other funds holding ZURA

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
ALPS Advisors
ALPS Advisors Denver, Colorado $21.8B AUM 17.58% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Golden State Wealth Management
Golden State Wealth Management Santa Ana, California $1.1B AUM 19.2% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Heritage Oak Wealth Advisors
Heritage Oak Wealth Advisors Santa Rosa Beach, Florida $329M AUM 19.43% 1-Year Est. Return
Y-Intercept (HK)
Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $184B AUM 51.71% 1-Year Est. Return

Barclays's ZURA Position: Q3 2026 in Review

Barclays increased its Zura Bio (ZURA) stake by 145% in Q3 2026, buying an estimated $817K and bringing the position to 258,666 shares worth $1.08M. The position accounts for ﹤0.01% of the portfolio, ranked #3000.

Barclays first reported a position in ZURA in Q2 2023 and has held it in 14 quarters since. 34 funds tracked by Wall St. Rank hold ZURA as of Q3 2026.

  • Barclays held 258,666 shares of Zura Bio worth $1.08M as of Q3 2026.
  • Barclays bought 152,920 Zura Bio shares in Q3 2026, an estimated $817K.
  • Zura Bio made up ﹤0.01% of Barclays's portfolio in Q3 2026, its #3000 holding.
  • Barclays first reported a position in Zura Bio in Q2 2023 and has held it in 14 quarters since.
  • 34 funds tracked by Wall St. Rank held Zura Bio as of Q3 2026.

Based on Barclays's 13F filing for Q3 2026, filed 6 Nov 2026.